Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?
- PMID: 37605003
- DOI: 10.1038/s41584-023-01013-4
Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?
Comment in
-
Reply to: Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?Nat Rev Rheumatol. 2023 Oct;19(10):676. doi: 10.1038/s41584-023-01014-3. Nat Rev Rheumatol. 2023. PMID: 37605004 No abstract available.
Comment on
-
State-of-the-art evidence in the treatment of systemic sclerosis.Nat Rev Rheumatol. 2023 Apr;19(4):212-226. doi: 10.1038/s41584-023-00909-5. Epub 2023 Feb 27. Nat Rev Rheumatol. 2023. PMID: 36849541 Free PMC article. Review.
Similar articles
-
Reply to: Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?Nat Rev Rheumatol. 2023 Oct;19(10):676. doi: 10.1038/s41584-023-01014-3. Nat Rev Rheumatol. 2023. PMID: 37605004 No abstract available.
-
Interstitial Lung Disease: How Should Therapeutics Be Implemented?Rheum Dis Clin North Am. 2023 May;49(2):279-293. doi: 10.1016/j.rdc.2023.01.005. Rheum Dis Clin North Am. 2023. PMID: 37028835 Review.
-
Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease.Expert Rev Clin Immunol. 2020 Jun;16(6):547-560. doi: 10.1080/1744666X.2020.1777857. Epub 2020 Jun 17. Expert Rev Clin Immunol. 2020. PMID: 32506975 Review.
-
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.Arthritis Res Ther. 2018 Jan 30;20(1):17. doi: 10.1186/s13075-018-1517-z. Arthritis Res Ther. 2018. PMID: 29382380 Free PMC article.
-
[Interstitial lung disease in systemic sclerosis].Rev Mal Respir. 2007 Oct;24(8):1035-46. doi: 10.1016/s0761-8425(07)92767-9. Rev Mal Respir. 2007. PMID: 18033190 Review. French.
Cited by
-
Reply to: Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?Nat Rev Rheumatol. 2023 Oct;19(10):676. doi: 10.1038/s41584-023-01014-3. Nat Rev Rheumatol. 2023. PMID: 37605004 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical